Watch study for heart monitoring in lymphoma or sarcoma patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study uses a wearable device to monitor heart health in people treated for lymphoma or sarcoma. It aims to detect heart changes early, which may help prevent long-term heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lymphoma or sarcoma.
- You are about to start or have completed anthracycline chemotherapy within the past year.
- You are willing to wear a device and follow study procedures for the entire study.
- You have a normal heart function (LVEF of 50% or higher) at the start.
- You do not have a history of heart failure, persistent atrial fibrillation, left bundle branch block, or a paced heartbeat.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supervised exercise program can improve heart health in people who finished treatment for Hodgkin or aggressive non-Hodgkin lymphoma 2–5 years ago. The goal is to see if regular exercise helps your heart recover better after chemotherapy or chest radiation.
This study tests whether a wearable heart monitor can help detect heart problems early in people receiving cancer treatment. It may help doctors manage heart health during therapy.
This study uses a smartwatch to monitor your activity and recovery after treatment for sarcoma or bone cancer in your leg or pelvis. It helps your care team keep track of how you're doing from home.
This study tests whether using an Apple Watch and a health app on your iPhone can help monitor how you're doing during chemotherapy. Doctors want to see if tracking your health at home can catch problems early and keep you safer.
This study uses a wearable wrist device to monitor your health data and look for early signs of heart problems. It's for people with or without heart disease, and involves wearing a watch-like device and using a smartphone app.
This study uses wearable technology (like smartwatches) to monitor your health and quality of life while you receive treatment for blood cancers like myeloma or myelodysplastic syndromes. The goal is to help doctors better understand how blood transfusions and other supportive care affect how you feel day-to-day.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.